AbbVie Biotherapeutics Inc. Patent applications |
Patent application number | Title | Published |
20150259425 | COMPOSITIONS AND METHODS FOR PRODUCING GLYCOPROTEINS - The present disclosure relates to methods of producing antibodies with increased levels of non-fucosylated glycoforms by culturing mammalian cells in culture media with enhanced concentrations of glycine relative to traditional basal media. | 09-17-2015 |
20150010539 | ANTI-CD25 ANTIBODIES AND THEIR USES - The present disclosure relates to antibodies directed to CD25 and uses of such antibodies, for example to suppress organ transplant rejection or to treat multiple sclerosis. | 01-08-2015 |
20150010538 | ANTI-CD25 ANTIBODIES AND THEIR USES - The present disclosure relates to antibodies directed to CD25 and uses of such antibodies, for example to suppress organ transplant rejection or to treat multiple sclerosis. | 01-08-2015 |
20140377253 | FC VARIANTS - The present disclosure relates to polypeptide variants having modified Fc domains with altered affinity to Fc receptors. | 12-25-2014 |
20140356351 | METHODS OF TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS - The present disclosure relates to methods of treating individuals suffering from progressive forms of multiple sclerosis. | 12-04-2014 |
20140212424 | ANTI-TNF-ALPHA ANTIBODIES AND THEIR USES - The present disclosure relates to antibodies directed to the tumor necrosis factor alpha (“TNF-α”) and uses of such antibodies, for example, to treat diseases associated with the activity and/or overproduction of TNF-α. | 07-31-2014 |
20140154255 | ANTI-VEGF ANTIBODIES AND THEIR USES - The present disclosure relates to antibodies directed to vascular endothelial growth factor (“VEGF”) and uses of such antibodies, for example to treat diseases associated with the activity and/or overproduction of VEGF. | 06-05-2014 |
20140037540 | COMPOSITIONS AGAINST CANCER ANTIGEN LIV-1 AND USES THEREOF - Described herein are methods and compositions that can be used for diagnosis and treatment of cancer. | 02-06-2014 |
20130330338 | CTLA4 PROTEINS AND THEIR USES - The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses. | 12-12-2013 |